Integrated metabolomic profiling for analysis of antilipidemic effects of Polygonatum kingianum extract on dyslipidemia in rats.

CONCLUSION: P. kingianum alleviates HFD-induced dyslipidemia by regulating many endogenous metabolites in serum, urine and liver samples. Collectively, our findings suggest that P. kingianum may be a promising lipid regulator to treat dyslipidemia and associated diseases.
PMID: 30622379 [PubMed - in process]

Source: World Journal of Gastroenterology - December 28, 2018 Category: Gastroenterology Authors: Yang XX, Wei JD, Mu JK, Liu X, Dong JC, Zeng LX, Gu W, Li JP, Yu J Tags: World J Gastroenterol Source Type: research